Corporate Board Profile
Tech Score: 6/100
1 mention(s) identify RAKESH K. JAIN, PH.D. as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| abrdn Healthcare Investors | 2022-04-12 | Dr. Jain is the A. W. Cook Professor of Radiation Oncology (Tumor Biology) at Harvard Medical School... Prior to joining Harvard, he was professor of chemical engineering at Columbia University and Carnegie Mellon University. | Dr. Jain has a Ph.D. and is a pioneer in tumor biology, drug delivery, in vivo imaging and bioengineering, with a background in chemical engineering and academia, indicating strong technical and scientific expertise. |
| Filing Date | Source Excerpt |
|---|---|
| 2007-05-10 | Rakesh K. Jain, Ph.D. (56), Director (since 1991), Steele Lab, Department of Radiation Oncology at Massachusetts General Hospital; A.W. Cook Professor of Radiation Oncology (since 1991) at Harvard Medical School; Ad hoc Consultant/Scientific Advisory Board member (various times since 2002) for pharmaceutical/biotech companies; Ad hoc Consultant (since 2004) for Gershon Lehman Group; Advisory Committee Member (since 2004) of Department of Biotechnology, Government of India. |
| 2008-05-05 | Rakesh K. Jain, Ph.D. Trustee of HQH and HQL (since 2007); Director, Steele Lab, Department of Radiation Oncology at Massachusetts General Hospital (since 1991); A.W. Cook Professor of Radiation Oncology at Harvard Medical School (since 1991); Ad hoc Consultant/Scientific Advisory Board Member for pharmaceutical/biotech companies (various times since 2002); Ad hoc Consultant for Gershon Lehman Group (since 2004); Advisory Committee Member of Department of Biotechnology, Government of India (2004-2007). |
| 2009-05-01 | Director, Steele Lab of Tumor Biology at Massachusetts General Hospital (since 1991); A.W. Cook Professor of Radiation Oncology at Harvard Medical School (since 1991) |
| 2010-04-27 | Trustee, HQH and HQL (since 2007); Director, Steele Lab of Tumor Biology at Massachusetts General Hospital (since 1991); A.W. Cook Professor of Tumor Biology (Radiation Oncology), Harvard Medical School (since 1991) |
| 2011-06-08 | Dr. Rakesh Jain is the Andrew Werk Cook Professor of Tumor Biology in the Department of Radiation Oncology at Harvard Medical School and the Director of the Edwin L. Steele Laboratory of Tumor Biology at Massachusetts General Hospital. |
| 2012-04-30 | Dr. Jain is regarded as a pioneer in the fields of tumor biology, drug delivery, in vivo imaging and bioengineering. He has authored more than 520 publications and serves on advisory panels to government, industry and academia. |
| 2013-04-25 | Dr. Jain is regarded as a pioneer in the fields of tumor biology, drug delivery, in vivo imaging and bioengineering. He has authored more than 570 publications and serves on advisory panels to government, industry and academia. |
| 2014-04-30 | Dr. Jain is regarded as a pioneer in the fields of tumor biology, drug delivery, in vivo imaging and bioengineering. He has authored more than 570 publications and serves on advisory panels to government, industry and academia. |
| 2015-04-20 | Dr. Jain is regarded as a pioneer in the fields of tumor biology, drug delivery, in vivo imaging and bioengineering. Dr. Jain has authored more than 600 publications. He serves on advisory panels to government, industry and academia, and has served or continues to serve on editorial advisory boards of twenty journals, including Journal of Clinical Oncology and Nature Reviews Clinical Oncology. |
| 2016-04-18 | Dr. Jain is regarded as a pioneer in the fields of tumor biology, drug delivery, in vivo imaging and bioengineering. Dr. Jain has authored more than 600 publications. |
| 2017-04-18 | Dr. Jain is regarded as a pioneer in the fields of tumor biology, drug delivery, in vivo imaging and bioengineering. Dr. Jain has authored more than 600 publications. He serves on advisory panels to government, industry and academia, and has served or continues to serve on editorial advisory boards of twenty journals. |
| 2018-04-18 | Dr. Jain is regarded as a pioneer in the fields of tumor biology, drug delivery, in vivo imaging and bioengineering. He has authored more than 600 publications and serves on advisory panels to government, industry and academia. |
| 2020-04-14 | Dr. Rakesh Jain is the A. W. Cook Professor of Radiation Oncology (Tumor Biology) at Harvard Medical School and the Director of the E. L. Steele Laboratories of Tumor Biology at Massachusetts General Hospital... Prior to joining Harvard, he was professor of chemical engineering at Columbia University and Carnegie Mellon University. Dr. Jain is regarded as a pioneer in the fields of tumor biology, drug delivery, in vivo imaging and bioengineering. |
| 2021-04-13 | Dr. Rakesh Jain is the A. W. Cook Professor of Radiation Oncology (Tumor Biology) at Harvard Medical School... Dr. Jain is regarded as a pioneer in the fields of tumor biology, drug delivery, in vivo imaging and bioengineering. |
| 2022-04-12 | Dr. Jain is the A. W. Cook Professor of Radiation Oncology (Tumor Biology) at Harvard Medical School... Prior to joining Harvard, he was professor of chemical engineering at Columbia University and Carnegie Mellon University. |
| 2023-04-11 | Dr. Jain is the A. W. Cook Professor of Radiation Oncology (Tumor Biology) at Harvard Medical School... Prior to joining Harvard, he was professor of chemical engineering at Columbia University and Carnegie Mellon University. |
Data sourced from SEC filings. Last updated: 2025-07-01